Overview

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

Status:
Completed

Trial end date:
2023-02-28

Target enrollment:
0

Participant gender:
All

Summary

To explore the potential efficacy of 18F-FAPI-04 PET/CT for PDAC tumour staging and compare the results with those obtained using 18F-FDG PET/CT.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Zhejiang University

Treatments:

Fluorodeoxyglucose F18

Criteria

Inclusion Criteria:

patients who were suspected to have PDAC by radiological imaging patients who underwent
paired 18F-FAPI-04 PET/CT and 18F-FDG PET/CT for metastasis screening, recurrence
confirmation, or tumour staging patients who were willing to participate in clinical trials
and signed an informed consent form.

Exclusion Criteria:

patients with a history of severe contrast allergy pregnant patients patients who were not
pathologically diagnosed as showing PDAC.